Navigation Links
Results of the PARTNER Trial Cohort B 2-year follow up presented at TCT 2011
Date:11/10/2011

SAN FRANCISCO, CA NOVEMBER 10, 2011 A two-year study of patients in the landmark PARTNER trial, which compared transcatheter aortic valve replacement (TAVR) in patients who have severe aortic stenosis and are not candidates for open heart surgery, confirm the one-year findings and support the role of TAVR as the standard of care.

Trial results were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

Cohort B of the PARTNER trial those patients with severe aortic stenosis who were not candidates for surgery - randomized 358 patients to transfemoral TAVR with an early generation balloon-expandable bovine pericardial valve or standard therapy (ST, including balloon valvuloplasty) at 21 centers, emphasizing a multi-disciplinary heart team approach.

The primary end point was death from any cause at one year and secondary endpoints included symptom status, serial echo assessments (core lab) and early/late adverse events (e.g. strokes).

After two years, the rate of all cause mortality was 18.2% in the TAVR group and 35.1% in the standard therapy group. The rate of cardiovascular mortality was 13.2% in the TAVR group and 32.1% in the standard therapy group.

The rate of repeat hospitalization was 35.0% in the TAVR group and 72.5% in the standard therapy group.

The rate of stroke at two years was higher 13.8% in the TAVR group and 5.5% in the standard therapy group.

"At two years, in patients with symptomatic severe aortic stenosis who are not suitable candidates for surgery, TAVR remained superior to standard therapy with incremental benefit from one to two years markedly reducing the rates of all cause mortality, cardiovascular mortality and repeat hospitalization," said Raj R. Makkar, MD, the principal site investigator for the PARTNER trial. Dr. Makkar is Director of Interventional Cardiology an
'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2009 Financial Results
2. SXC Health Solutions to Host Fiscal 2009 Fourth Quarter and Year End Results Conference Call
3. Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results
4. First blinded study of venous insufficiency prevalence in MS shows promising results
5. NEJM Publishes Trial Results Demonstrating Bard FLAIR Endovascular Stent Graft Is Superior To Balloon Angioplasty For Failing Dialysis Grafts
6. BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
7. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
8. United American Healthcare Corporation Announces Fiscal 2010 Second Quarter Results
9. Fitness Trend Towards Online Personal Training Gets Real-World Weight Loss Results on FitOrbit.com
10. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
11. WebMD Announces Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... After record-breaking sales of Extend ... introduces the Cookies & Cream flavor at stores nationwide ... has continually raised the bar for nutritional snacks. ... an unprecedented nutritional profile, backed by international patents and ... will launch additional new products and expand retail availability ...
(Date:5/5/2015)... 2015 Dealing with injuries and medical expenses ... task. Personal injury lawyers are excellent resources for accident victims ... In their latest article , the Jones Firm gives the ... choosing a personal injury lawyer to handle their case. , ... a waste of time if the lawyer does not have ...
(Date:5/5/2015)... The report “Liver Fibrosis ... analysis on the therapeutic development for Liver ... identifying new targets and MOAs to produce ... available at http://www.rnrmarketresearch.com/liver-fibrosis-pipeline-review-h2-2014-market-report.html . , ... Pipeline Review, H2 2014 report include ACROVIS ...
(Date:5/5/2015)... 2015 Texting has become a common and ... some physicians text as a way to communicate with patients ... are doing so to assure medical records are updated after ... risk! When providers transmit protected health information (PHI), or ... the risk of violating the Health Insurance Portability and Accountability ...
(Date:5/5/2015)... 05, 2015 No one cares about health ... Disease Control and Prevention cite multiple sources causing poor ... “Poor indoor air quality (pollution) can bother your eyes, nose, ... lung problems and cancer.” , Toxic chemicals often get into ... food or water, or in some cases, absorb them through ...
Breaking Medicine News(10 mins):Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 3Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3
... Pharmacologic Agent Developed for the Treatment of Premature ... ... Janssen-Cilag companies in,Europe have submitted a Marketing Authorisation Application (MAA) for,dapoxetine, ... Premature ejaculation is a form of male sexual dysfunction associated,with ...
... time, review shows , , FRIDAY, Dec. 7 (HealthDay News) -- The ... of death, from suicide as well as other causes, a new ... days following the loss. , More research needs to be done ... according to the article in the Dec. 8 issue of ...
... PRINCETON, N.J., Dec. 7 Medarex, Inc.,(Nasdaq: ... an undisclosed,milestone payment from its licensing partner, Centocor, ... of ustekinumab,(CNTO 1275) in the United States and ... severe plaque psoriasis by Centocor., Ustekinumab is ...
... CNN Worldwide and its global audience,paid special tribute tonight ... as "CNN Heroes" in a global telecast.,CNN,s Anderson Cooper ... the American Museum of Natural History in New York,City., ... initiative has shone a,spotlight upon dozens of amazing people ...
... Mass., Dec. 6 Inverness Medical,Innovations, Inc. (Amex: ... of rapid,diagnostic products for the consumer and professional ... 2007 RBC Capital Markets Healthcare,Conference being held December ... City. Ron Zwanziger, Chief Executive Officer, and Jon ...
... Dec. 6 A gene related to rapid replication ... to contain some identical,protein sequences in, tobacco mosaic virus ... for cancer, the AMAS(R) test, appears,to measure this gene,s ... of reports on the use of a new,methodology to ...
Cached Medicine News:Health News:Submission of Marketing Authorisation Application for Dapoxetine in Europe 2Health News:Mourning Death of Loved One Raises Your Risk of Dying 2Health News:Mourning Death of Loved One Raises Your Risk of Dying 3Health News:Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis 2Health News:Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis 3Health News:CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event 2Health News:CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event 3Health News:CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event 4Health News:Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 3
(Date:5/4/2015)... 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... has joined the company as Vice President, Medical Affairs. ... Dr. Bill Aurora to the Neurocrine team ... Gorman , President and Chief Executive Officer of Neurocrine ... and outreach coupled with his extensive network and influence ...
(Date:5/4/2015)... Microbrush International, a leading developer, producer and ... procedures, today announced the acquisition of DentiSmart LLC. ... matrix system used in dental restorative procedures. ... to add DentiSmart to our growing portfolio of ... and General Manager of Microbrush. "DentiSmart,s products are ...
(Date:5/4/2015)... , May 4, 2015  The board of directors of ... a dividend for the second quarter of 2015 of $0.50 ... dividend is payable June 10, 2015, to shareholders of record ... About Eli Lilly and Company Lilly is a global healthcare ... for people around the world. We were founded more than ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the Stifel Nicolaus Healthcare ... 2:40 p.m. Eastern Time.  Dr. Sands will provide an ...
... Aug. 30, 2011 Reportlinker.com announces that a ... its catalogue: Specialty Pharmaceutical ... http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry---2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Summary ... Industry - 2011 Yearbook" essentially provides insights ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference 2Specialty Pharmaceutical Industry - 2011 Yearbook 2Specialty Pharmaceutical Industry - 2011 Yearbook 3Specialty Pharmaceutical Industry - 2011 Yearbook 4Specialty Pharmaceutical Industry - 2011 Yearbook 5Specialty Pharmaceutical Industry - 2011 Yearbook 6Specialty Pharmaceutical Industry - 2011 Yearbook 7Specialty Pharmaceutical Industry - 2011 Yearbook 8Specialty Pharmaceutical Industry - 2011 Yearbook 9Specialty Pharmaceutical Industry - 2011 Yearbook 10Specialty Pharmaceutical Industry - 2011 Yearbook 11Specialty Pharmaceutical Industry - 2011 Yearbook 12Specialty Pharmaceutical Industry - 2011 Yearbook 13Specialty Pharmaceutical Industry - 2011 Yearbook 14Specialty Pharmaceutical Industry - 2011 Yearbook 15Specialty Pharmaceutical Industry - 2011 Yearbook 16
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 12 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
Medicine Products: